ANTITHROMBOTIC THERAPY IN PATIENTS WITH VALVULAR HEART DISEASE: WHAT'S NEW?

N. A. Shostak; A. A. Klimenko; D. Yu. Andriyashkina; N. A. Demidova

doi:10.17650/1818-8338-2017-11-2-10-15

Klinicist (Dec 2017)

ANTITHROMBOTIC THERAPY IN PATIENTS WITH VALVULAR HEART DISEASE: WHAT'S NEW?

N. A. Shostak,
A. A. Klimenko,
D. Yu. Andriyashkina,
N. A. Demidova

Affiliations

N. A. Shostak: N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia.
A. A. Klimenko: N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia.
D. Yu. Andriyashkina: N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia.
N. A. Demidova: N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia.

DOI: https://doi.org/10.17650/1818-8338-2017-11-2-10-15
Journal volume & issue: Vol. 11, no. 2
pp. 10 – 15

Abstract

Read online

The article presents an overview of modern data and an analysis of the recommendations of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery published in 2017 regarding the use of antithrombotic therapy in patients with valvular heart disease. The results of studies devoted to the use of new oral anticoagulants in patients with valvular heart disease are demonstrated.

Published in Klinicist

ISSN: 1818-8338 (Print)
Publisher: ABV-press
Country of publisher: Russian Federation
LCC subjects: Medicine
Website: http://klinitsist.abvpress.ru/

About the journal

Abstract

Keywords